Live Breaking News & Updates on Rapport Therapeutics

Stay updated with breaking news from Rapport therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test

Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Goldman-sachs , Nasdaq , Johnson , Rapport-therapeutics , Third-rock-ventures , Johnson-innovation , Venture-partners , Sofinnova-ventures

Rapport Therapeutics, Inc. Plans $136 Million IPO for June 7th (RAPP)

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an initial public offering (IPO) on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for […] ....

California , United-states , San-francisco , Delaware , Boston , Massachusetts , David-bredt , Eli-lilly , News-ratings-for-rapport-therapeutics-inc , University-of-california , Goldman-sachs , Rapport-therapeutics-inc

Rapport Therapeutics, Inc. (RAPP) Announces June 7th IPO

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at a price of $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […] ....

San-francisco , California , United-states , Delaware , Boston , Massachusetts , David-bredt , Eli-lilly , Goldman-sachs , News-ratings-for-rapport-therapeutics-inc , Rapport-therapeutics-inc , University-of-california

Rapport Therapeutics, Inc. (RAPP) to Raise $136 Million in IPO

Rapport Therapeutics, Inc. (RAPP) is planning to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company plans to issue 8,000,000 shares at a price of $16.00-$18.00 per share. The company has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […] ....

California , United-states , San-francisco , Delaware , Boston , Massachusetts , David-bredt , Eli-lilly , Goldman-sachs , University-of-california , News-ratings-for-rapport-therapeutics-inc , Rapport-therapeutics-inc

Hedge Funds Hope to Cash in on Biopharma IPO

Hedge Funds Hope to Cash in on Biopharma IPO
institutionalinvestor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from institutionalinvestor.com Daily Mail and Mail on Sunday newspapers.

Raymond-kelleher , Cormorant-private-healthcare-fund , Cormorant-global-healthcare-master-fund , Rapport-therapeutics , Cormorant-asset , Global-healthcare-master-fund , Perceptive-advisors , Surveyor-capital , Third-rock-ventures , Johnson-innovation ,